CIK: 1226488 - Address: 350 Oyster Point Blvd, South San Francisco, CA 94080
42 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret113121-17-5-14-5
P%wins10067670505056
S%ret1160-22-9-3-13-4
S%wins676750836710072

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

4/25/24 18:54
4/25/24
CYTKCytokinetics IncHealthDrugPharmaceutical PreparationsHenderson John TCADS-68264.540-11-2532D
2/14/24 16:04
2/14/24
CYTKCytokinetics IncHealthDrugPharmaceutical PreparationsHenderson John TCADM.d224.44051343D
2/14/24 16:04
2/14/24
CYTKCytokinetics IncHealthDrugPharmaceutical PreparationsHenderson John TCADS.d-38276.480-5-1043D
1/12/24 17:20
1/12/24
CYTKCytokinetics IncHealthDrugPharmaceutical PreparationsHenderson John TCADM.d224.44051343D
1/12/24 17:20
1/12/24
CYTKCytokinetics IncHealthDrugPharmaceutical PreparationsHenderson John TCADS.d-42685.140-5-1043D
12/19/23 16:12
12/18/23
CYTKCytokinetics IncHealthDrugPharmaceutical PreparationsHenderson John TCADM.d876.720134442D
12/19/23 16:12
12/18/23
CYTKCytokinetics IncHealthDrugPharmaceutical PreparationsHenderson John TCADS.d-8936.340-2-542D
5/15/23 16:07
5/15/23
CYTKCytokinetics IncHealthDrugPharmaceutical PreparationsHenderson John TCADM.d286.78042026D
5/15/23 16:07
5/15/23
CYTKCytokinetics IncHealthDrugPharmaceutical PreparationsHenderson John TCADS.d-15737.770-4-1426D
9/12/22 16:27
9/12/22
CYTKCytokinetics IncHealthDrugPharmaceutical PreparationsHenderson John TCADM.d874.0202291724D
9/12/22 16:27
9/12/22
CYTKCytokinetics IncHealthDrugPharmaceutical PreparationsHenderson John TCADS.d-1,19654.950-22-4724D
3/1/22 19:48
3/1/22
CYTKCytokinetics IncHealthDrugPharmaceutical PreparationsHenderson John TCADM.d235.46043018D
11/5/21 18:33
11/5/21
CYTKCytokinetics IncHealthDrugPharmaceutical PreparationsHenderson John TCADM.d505.880917613D
11/5/21 18:33
11/5/21
CYTKCytokinetics IncHealthDrugPharmaceutical PreparationsHenderson John TCADS.d-34040.000-9-3913D
4/8/21 18:13
5/19/20
CYTKCytokinetics IncHealthDrugPharmaceutical PreparationsHenderson John TCADM.a5616.8603937D
4/5/21 18:50
4/1/21
CYTKCytokinetics IncHealthDrugPharmaceutical PreparationsHenderson John TCADM.d298.6403807D
4/5/21 18:50
4/1/21
CYTKCytokinetics IncHealthDrugPharmaceutical PreparationsHenderson John TCADS.d-7823.540-3-317D
12/31/20 16:55
12/31/20
CYTKCytokinetics IncHealthDrugPharmaceutical PreparationsHenderson John TCADM.d1112.96016921D
12/31/20 16:55
12/31/20
CYTKCytokinetics IncHealthDrugPharmaceutical PreparationsHenderson John TCADS.d-1720.310-1-471D
10/5/20 21:03
10/5/20
CYTKCytokinetics IncHealthDrugPharmaceutical PreparationsHenderson John TCADM.d3912.96031D
10/5/20 21:03
10/5/20
CYTKCytokinetics IncHealthDrugPharmaceutical PreparationsHenderson John TCADS.d-8729.000-3-751D
5/20/20 17:04
5/19/20
CYTKCytokinetics IncHealthDrugPharmaceutical PreparationsHenderson John TCADM.d5616.86031D
1/2/20 14:22
11/19/19
CYTKCytokinetics IncHealthDrugPharmaceutical PreparationsHenderson John TCADP518.5706999%6D
11/7/19 13:05
11/7/19
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticHenderson John TUTDP16423.46071266M
9/5/17 14:08
9/1/17
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticHenderson John TUTDM.d49416.4603023443D
9/5/17 14:08
9/1/17
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticHenderson John TUTDS.d-90930.300-30-4143D
2/23/17 11:20
2/22/17
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticHenderson John TUTDP.m11218.663361643D-46-46-1112817189132
9/13/16 10:38
9/9/16
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticHenderson John TUTDM.dm31810.60333022D-43-46-44-32-33-13300-9-17-8
9/13/16 10:38
9/9/16
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticHenderson John TUTDS.dm-61520.4933-30-5822D-43-46-44-32-33-13300-9-17-8
6/6/14 11:50
6/5/14
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticHenderson John TUTDM.d387.603354D531638-6-12-7450-472-2-6
6/6/14 11:50
6/5/14
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticHenderson John TUTDS.d-17935.7033-5-544D531638-6-12-7450-472-2-6
3/11/14 17:05
3/7/14
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticHenderson John TUTDM.d1527.6033204D59503649478312115060
3/11/14 17:05
3/7/14
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticHenderson John TUTDS.d-75737.8633-20-824D59503649478312115060
3/7/14 17:01
3/5/14
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticHenderson John TUTDM.d387.603354D534937464921-11-1-98-8-6-8
3/7/14 17:01
3/5/14
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticHenderson John TUTDS.d-18837.5933-5-544D534937464921-11-1-98-8-6-8
1/25/13 20:17
1/18/13
MYRXMyrexis, Inc.DEHealthDrugPharmaceutical PreparationsHenderson John TUTDM.d511.56033999%34D
12/11/12 17:13
12/10/12
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticHenderson John TUTDM.d2686.7031404D25342036-10-70-1-3-4-722-14
12/11/12 17:13
12/10/12
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticHenderson John TUTDS.d-1,10627.6531-40-904D25342036-10-70-1-3-4-722-14
5/14/09 11:07
5/13/09
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticHenderson John TUTDP1032.7333084I7457-9-25-28-15-1460317-10-19-36
2/5/09 16:17
2/5/09
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticHenderson John TUTDM.d17217.233310213-7-23-31-39
2/5/09 16:17
2/5/09
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticHenderson John TUTDS.d-82582.4633-10-83213-7-23-31-39
5/11/04 17:48
5/11/04
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticHenderson John TUTDP3417.03162New2D-232133-450-9-93-1-15-2398

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact